Prion diseases;Enfermedades priónicas o prionpatías

Neurologia

Volumn 21, Issue 8, 2006, Pages 395-399

  Zarranz, Juan J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Creutzfeldt Jakob disease; Prion; Spongiform encephalopathies

Indexed keywords

ANIMAL; CLASSIFICATION; EDITORIAL; EUROPE; HEALTH SURVEY; HUMAN; PATHOPHYSIOLOGY; PRION DISEASE;

ANIMALS; EUROPE; HUMANS; POPULATION SURVEILLANCE; PRION DISEASES;

EID: 39049190586     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Moreno Izco F, Arriola Larrarte L. Neuroimagen en el diagnóstico de las encefalopatías espongiformes transmisibles humanas. Neurología 2006;21:428-36.
2. Sánchez-Valle R, Santamaría J, Rey MJ, Rodríguez A, Graus F, Saiz A. Enfermedad de Creutzfeldt-Jakob esporádica, variante MM1, asociada a mutismo acinético de larga duración. Neurología 2006;21:444-6.
3. Pascual Lozano AM, Salvador Aliaga A, Coret Ferrer F, Láinez Andrés JM. Evolución clínicorradiológica atípica en un caso de variante encefalopática de la enfermedad de Creutzfeldt-Jakob. Neurología 2006;21:439-43.
4. Riverol M, Arbizu J, Luquin MR. Neuroimagen en la enfermedad de Creutzfeldt-Jakob. Neurología 2006;21:437-8.
5. Ayuso Blanco T, Urriza Mena J, Caballero Martínez C, Iriarte Franco J, Muñoz Arrondo R, García-Bragado F. Insomnio letal familiar: estudio clínico, neurofisiológico e histopatoló gico de dos casos. Neurología 2006;21:414-20.
6. Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51-61.
7. Collinge J. Molecular neurology of prion diseases. J Neurol Neurosurg Psychiatry 2005;76:906-19.
8. Prusiner SB. Shattuck lecture-neurodegenerative diseases and prions. N Engl J Med 2001;344:1516-26.
9. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, et al. Search for a prion-specific nucleic acid. J Virol 2005;79:10796-806.
10. Aguzzi A, Heikenwalder M. Prion diseases. Cannibals and garbage piles. Nature 2003;423:127-28.
11. Matthews WB. Epidemiology of Creutzfeldt-Jakob Disease in England and Wales, J Neurol Neurosurg Psychiatry 1975;38:210-3.
12. Brown P, Cathala F, Gajdusek DC. Creutzfeldt-Jakob disease in France: III. Epidemiological study of 170 patients dying during the decade 1968-1977. Ann Neurol 1979;6:438-46.
13. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895-904.
14. Brown P, Brandel JP, Preese M, Sato T. Iatrogenic Creutzfeldt-Jakob disease. The waning of an era. Neurology 2006;67:389-93.
15. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt Jakob disease by blood transfusion. Lancet 2004;363:417-21.
16. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
17. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-9.
18. Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ, et al. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 2006;367:2068-74.
19. Bishop MY, Hart P, Aitchison L. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006;5:393-8.
20. Lasmézas CI. Of mice and men... and vCJD. Lancet Neurol 2006;5:374-5.
21. Ironside JW, Bishop MT, Connoly K. Variant Creutzfeldt-Jakob disease: prion protein genotype analisis and positive appendix tissue samples from a retrospective prevalence study. BMJ 2006;332:1166-8.
22. Saa P, Casilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006;313:92-4.
23. Trevitt C, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006;129:2241-65.
24. Hsich G, Kennedy K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med 1996;335:924-30.
25. Zerr I, Bodemer M, Gefelleer O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.
26. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfledt-Jakob disease. Neurology 2000;55:811-5.
27. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002;360:139-41.
28. Glatzel M, Ott PM, Linder T, Gebbers JO, Gmür A, Wüst W et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003;2:757-63.
29. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:669-80.
30. Parchi P, Giese A, Capellari S, Brown P, Schultz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46: 224-33.
31. Hill AF, Joiner S, Wadsworth JD, SidleKCL, Bell JE, Budka H, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003;126:1333-46.
32. Glatzel M, Stoeck K, Seeger H, Lührs T, Aguzzi A. Human prion diseases. Molecular and clinicals aspects. Arch Neurol 2005;62:545-52.
33. Head MW, Bunn T, Bishop MT, McLouglin V, Lowrie S, McKimmie CS, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004;55:851-9.
34. Lo RY-Y, Shyu WC, Li, H. Long-duration sCJD with PRNP codon 129 methionine homozygosity and cerebral cortical plaques. Neurology 2006;66:1944-5.
35. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrPsc in the same brain. Neurology 1999;53:2173-6.
36. Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A, Glatzel M. Analysis of prion strains by PrPsc profiling in sporadic Creutzfeldt-Jakob disease. PloS Med 2006;3:236-44.
37. Ironside JW, Ritchie DL, Head MW. Phenotypic variability in human prion diseases. Neuropathol Appl Neurobiol 2005;31:565-79.
38. Polymenidou M, Stoeck K, Glatzel M, Very M, Bellon A, Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 2005;4:805-14.
39. Haïk S, Peoc'h K, Brandel JP, Privat N, Laplanche JL, Faucheux BA, Hauw JJ. Striking PrPSc heterogeneity in inherited Prion diseases with the D178N mutation. Ann Neurol 2004;56:909-10.
40. Dickson DW, Brown P. Multiple prion type in the same brain. Is a molecular diagnosis de CJD posible? Neurology 1999;53:1903-4.
41. Zarranz JJ, Digon A, Atarés B, Rodríguez-Martínez AB, Arce A, Carrera N, et al. Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry 2005;76:1491-6.